Peter M. Hecht
2017 - Ironwood Pharmaceuticals
In 2017, Peter M. Hecht earned a total compensation of $6M as Former Chief Executive Officer at Ironwood Pharmaceuticals, a 41% increase compared to previous year.
Compensation breakdown
| Option Awards | $5,887,416 |
|---|---|
| Salary | $100,000 |
| Other | $8,040 |
| Total | $5,995,456 |
Hecht received $5.9M in option awards, accounting for 98% of the total pay in 2017.
Hecht also received $100K in salary and $8K in other compensation.
Rankings
In 2017, Peter M. Hecht's compensation ranked 1,466th out of 14,666 executives tracked by ExecPay. In other words, Hecht earned more than 90.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,466 out of 14,666 | 90th |
Division Manufacturing | 493 out of 5,772 | 92nd |
Major group Chemicals And Allied Products | 131 out of 2,075 | 94th |
Industry group Drugs | 94 out of 1,731 | 95th |
Industry Pharmaceutical Preparations | 73 out of 1,333 | 95th |
Source: SEC filing on April 26, 2019.
Hecht's colleagues
We found four more compensation records of executives who worked with Peter M. Hecht at Ironwood Pharmaceuticals in 2017.
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019